Analytical Data
-
Gene name
C20orf144
- Application
-
Alternative Names
C20orf144Uncharacterized Protein C20orf144; Bcl-2-like Protein from testis; Bclt
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BQM9
-
Expression Region
1-153aa
-
AA Sequence
MGNYSSHKRT KAPKQARKER PADMDKAWWK SFLNHLTRKK PATRIVLILP LDKRQPLANA GQRIDYASGA GLGSPAAPRL RGAGEGSERE PRMPVLLLLR RQEARRPEEG GARAALSWPR LLSRFRSPGK APREAGPAEE QPRKRCRCPR PQL
-
Molecular Weight
43.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C20orf144, also known as "Chromosome 20 Open Reading Frame 144," has garnered attention in recent years due to its potential implications in various biological processes and conditions. As a relatively uncharacterized protein, initial studies have suggested its involvement in cellular functions such as cell proliferation, differentiation, and response to stress. Moreover, genomic analyses have linked C20orf144 to certain diseases, including cancer, where its expression levels may correlate with tumor progression and patient prognosis. Given the limited understanding of its structural and functional properties, researchers have increasingly focused on generating recombinant C20orf144 for in-depth studies. The production of this recombinant protein allows for a detailed exploration of its biochemical activities, interactions with other cellular molecules, and its role in signaling pathways. Furthermore, understanding C20orf144's functions could unveil novel therapeutic targets for disease management. Thus, the recombinant C20orf144 protein serves not only as a valuable tool for basic research but also as a potential candidate for clinical applications, paving the way for advancements in molecular medicine and targeted therapies. As ongoing studies continue to elucidate its biological significance, C20orf144 stands out as a promising area of investigation within the landscape of genomics and proteomics.











